Literature DB >> 27241971

Cardiovascular Risk in Growth Hormone Deficiency: Beneficial Effects of Growth Hormone Replacement Therapy.

Roberto Lanes1.   

Abstract

Growth hormone deficiency (GHD) in adulthood is associated with an increased risk of developing adverse cardiovascular events and with reduced life expectancy. Cardiovascular and metabolic abnormalities have so far been evaluated only in a small number of children with GHD and adolescents. In this article we review these abnormalities and their underlying mechanisms and discuss the beneficial effect of growth hormone treatment in subjects with GHD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac mass and function; Cardiovascular risk; Carotid intima-media thickness; Endothelial dysfunction; Growth hormone deficiency; Lipoprotein abnormalities; Vascular reactivity; Visceral adiposity

Mesh：

Substances：

Year:  2016        PMID： 27241971     DOI： 10.1016/j.ecl.2016.01.005

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  9 in total

1.  Adult Growth Hormone Deficiency: Diagnostic and Treatment Journeys From the Patients' Perspective.

Authors:  Andrew R Hoffman; Tracy Mathison; Deno Andrews; Kristine Murray; Nicky Kelepouris; Maria Fleseriu
Journal:  J Endocr Soc       Date:  2022-05-12

2.  Meta-analysis of metabolic changes in children with idiopathic growth hormone deficiency after recombinant human growth hormone replacement therapy.

Authors:  Yuan Yuan; Bo Zhou; Shufang Liu; Yunfeng Wang; Kundi Wang; Zhixin Zhang; Wenquan Niu
Journal:  Endocrine       Date:  2020-08-01       Impact factor: 3.633

Review 3.  The Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity.

Authors:  Moira S Lewitt
Journal:  Biochem Insights       Date:  2017-04-20

Review 4.  Growth hormone replacement therapy reduces risk of cancer in adult with growth hormone deficiency: A meta-analysis.

Authors:  Zhanzhan Li; Qin Zhou; Yanyan Li; Jun Fu; Xinqiong Huang; Liangfang Shen
Journal:  Oncotarget       Date:  2016-12-06

5.  Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS).

Authors:  V Rochira; G Mossetto; N Jia; S Cannavo; P Beck-Peccoz; G Aimaretti; M R Ambrosio; C Di Somma; M Losa; D Ferone; C Lubrano; C Scaroni; A Giampietro; S M Corsello; M Poggi
Journal:  J Endocrinol Invest       Date:  2018-03-13       Impact factor: 4.256

Review 6.  Glucose Metabolism in Children With Growth Hormone Deficiency.

Authors:  Alessandro Ciresi; Carla Giordano
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-11       Impact factor: 5.555

7.  Association between triglyceride glucose index and peak growth hormone in children with short stature.

Authors:  Qianqian Zhao; Yuntian Chu; Hui Pan; Mei Zhang; Bo Ban
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

8.  Somatropin therapy in italian adults with growth hormone deficiency.

Authors:  Flavia Pricci; Daniela Rotondi; Marika Villa; Arianna Valerio; Elvira Agazio; Paolo Roazzi
Journal:  BMC Endocr Disord       Date:  2022-03-03       Impact factor: 2.763

Review 9.  Growth hormone deficiency and the transition from pediatric to adult care.

Authors:  Ana Beatriz Winter Tavares; Paulo Ferrez Collett-Solberg
Journal:  J Pediatr (Rio J)       Date:  2021-03-24       Impact factor: 2.990
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.